Copper-64 Radiopharmaceutical Precursor Market: Growth, Trends, and Forecast to 2026
The Copper-64 radiopharmaceutical precursor market was valued at USD 1.4 billion in 2022 and is projected to reach USD 3.3 billion by 2026, growing at a compound annual growth rate (CAGR) of 20.3% during the forecast period. Several factors contribute to this growth, including advancements in nuclear medicine, the increasing prevalence of cancer, and the rising demand for precise, personalized diagnostic and therapeutic treatments.
Read More -> https://marketintelo.com/repor....t/copper-64-radiopha
إعجاب
علق
شارك
